168 related articles for article (PubMed ID: 27986516)
1. Effects of withdrawal from repeated phencyclidine administration on behavioural function and brain arginine metabolism in rats.
Knox LT; Jing Y; Bawazier-Edgecombe J; Collie ND; Zhang H; Liu P
Pharmacol Biochem Behav; 2017 Feb; 153():45-59. PubMed ID: 27986516
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute phencyclidine administration on arginine metabolism in the hippocampus and prefrontal cortex in rats.
Knox LT; Jing Y; Collie ND; Zhang H; Liu P
Neuropharmacology; 2014 Jun; 81():195-205. PubMed ID: 24534111
[TBL] [Abstract][Full Text] [Related]
3. Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus.
Knox LT; Jing Y; Fleete MS; Collie ND; Zhang H; Liu P
Neuropharmacology; 2011 Dec; 61(8):1452-62. PubMed ID: 21903106
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice.
Beraki S; Diaz-Heijtz R; Tai F; Ogren SO
Int J Neuropsychopharmacol; 2009 Mar; 12(2):243-55. PubMed ID: 18684341
[TBL] [Abstract][Full Text] [Related]
5. Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats.
Gupta N; Jing Y; Collie ND; Zhang H; Liu P
Neuroscience; 2012 Dec; 226():178-96. PubMed ID: 22989918
[TBL] [Abstract][Full Text] [Related]
6. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
Schwabe K; Klein S; Koch M
Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
[TBL] [Abstract][Full Text] [Related]
7. Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice.
Li Z; Kim CH; Ichikawa J; Meltzer HY
Pharmacol Biochem Behav; 2003 May; 75(2):335-40. PubMed ID: 12873624
[TBL] [Abstract][Full Text] [Related]
8. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
[TBL] [Abstract][Full Text] [Related]
9. Repeated ethanol but not phencyclidine impairs spontaneous alternation behaviour in the Y-maze.
Götesson J; Ericson M; Söderpalm B; Pickering C
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):347-52. PubMed ID: 22004516
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions.
Hori T; Subramaniam S; Srivastava LK; Quirion R
Neuropharmacology; 2000 Sep; 39(12):2478-91. PubMed ID: 10974332
[TBL] [Abstract][Full Text] [Related]
11. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
12. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB
Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766
[TBL] [Abstract][Full Text] [Related]
13. Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7.
Boctor SY; Ferguson SA
Neurotoxicology; 2010 Jan; 31(1):42-54. PubMed ID: 19853622
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
[TBL] [Abstract][Full Text] [Related]
15. Perinatal administration of PCP alters adult behaviour in female Sprague-Dawley rats.
du Bois TM; Huang XF; Deng C
Behav Brain Res; 2008 Apr; 188(2):416-9. PubMed ID: 18177952
[TBL] [Abstract][Full Text] [Related]
16. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN
J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
[TBL] [Abstract][Full Text] [Related]
17. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.
Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407
[TBL] [Abstract][Full Text] [Related]
18. Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.
Pålsson E; Lowry J; Klamer D
Psychopharmacology (Berl); 2010 Dec; 212(4):643-51. PubMed ID: 20802999
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
20. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
Beraki S; Kuzmin A; Tai F; Ogren SO
Eur Neuropsychopharmacol; 2008 Jul; 18(7):486-97. PubMed ID: 18242064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
